Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers

被引:11
作者
Bagossi, P
Cheng, YSE
Oroszlan, S
Tözsér, J
机构
[1] Debrecen Univ Med, Sch Med, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary
[2] Dupont Merck Pharmaceut Co, Expt Stn, Wilmington, DE 19803 USA
[3] NCI, Mol Virol & Carcinogenesis Lab, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
来源
PROTEIN ENGINEERING | 1998年 / 11卷 / 06期
关键词
linked HIV proteinase dimers; heterodimers; oligo-peptide substrates; enzyme kinetics; substrate specificity;
D O I
10.1093/protein/11.6.439
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specificity of linked homo- and heterodimeric HIV-1 and HIV-2 proteinases was characterized by using oligopeptide substrates, For two substrates the k(cat)/K-m values for the heterodimers were the mean values for those of the homodimers, suggesting that these substrates could productively bind into the heterodimers in both directions, However, for two other substrates the k(cat)/K-m values for the heterodimers were higher than those of the homodimers, suggesting that these substrates could productively bind into the enzymes in a preferable direction. However, the mode of binding does not seem to depend on the sequential position of the subunits, The studied linked homo- and heterodimers may represent intermediate stages in the evolution of bilobal aspartic proteinases. As divergence in sequence of the two halves of such a proteinase increases, the possibility of bidirectional binding is likely lost at the expense of the optimized side-chain subsite interactions. The differences in observed and calculated k(cat)/K-m values revealed dependence of the substrate specificity at one subsite of the enzyme from the next residue in sequence of substrate. These findings were also supported by molecular modeling studies.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 44 条
[1]   Activity of linked HIV-1 proteinase dimers containing mutations in the active site region [J].
Bagossi, P ;
Cheng, YSE ;
Oroszlan, S ;
Tozser, J .
PROTEIN ENGINEERING, 1996, 9 (11) :997-1003
[2]   CRYSTAL-STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEINASE COMPLEXED WITH AND INHIBITOR [J].
BHAT, TN ;
BALDWIN, ET ;
LIU, BS ;
CHENG, YSE ;
ERICKSON, JW .
NATURE STRUCTURAL BIOLOGY, 1994, 1 (08) :552-556
[3]  
CHEN ZG, 1994, J BIOL CHEM, V269, P26344
[4]   STABILITY AND ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - COMPARISON OF THE NATURAL DIMER WITH A HOMOLOGOUS, SINGLE-CHAIN TETHERED DIMER [J].
CHENG, YSE ;
YIN, FH ;
FOUNDLING, S ;
BLOMSTROM, D ;
KETTNER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9660-9664
[5]   GENETIC-LOCUS, PRIMARY STRUCTURE, AND CHEMICAL SYNTHESIS OF HUMAN IMMUNODEFICIENCY VIRUS PROTEASE [J].
COPELAND, TD ;
OROSZLAN, S .
GENE ANALYSIS TECHNIQUES, 1988, 5 (06) :109-115
[6]  
DILANNI C L, 1990, Journal of Biological Chemistry, V265, P17348
[7]   A SYMMETRICAL INHIBITOR BINDS HIV-1 PROTEASE ASYMMETRICALLY [J].
DREYER, GB ;
BOEHM, JC ;
CHENERA, B ;
DESJARLAIS, RL ;
HASSELL, AM ;
MEEK, TD ;
TOMASZEK, TA .
BIOCHEMISTRY, 1993, 32 (03) :937-947
[8]   DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE [J].
ERICKSON, J ;
NEIDHART, DJ ;
VANDRIE, J ;
KEMPF, DJ ;
WANG, XC ;
NORBECK, DW ;
PLATTNER, JJ ;
RITTENHOUSE, JW ;
TURON, M ;
WIDEBURG, N ;
KOHLBRENNER, WE ;
SIMMER, R ;
HELFRICH, R ;
PAUL, DA ;
KNIGGE, M .
SCIENCE, 1990, 249 (4968) :527-533
[9]  
FERSHT A, 1985, ENZYME STRUCTUR MECH
[10]  
GRIFFITH JT, 1994, J BIOL CHEM, V269, P7487